Literature DB >> 15194909

In vivo measurement of gadolinium concentration in a rat glioma model by monochromatic quantitative computed tomography: comparison between gadopentetate dimeglumine and gadobutrol.

Géraldine Le Duc1, Stéphanie Corde, Anne-Marie Charvet, Hélène Elleaume, Régine Farion, Jean-François Le Bas, François Estève.   

Abstract

RATIONALE AND
OBJECTIVES: Monochromatic quantitative computed tomography allows a nondestructive and quantitative measurement of gadolinium (Gd) concentration. This technique was used in the C6 rat glioma model to compare gadopentetate dimeglumine and gadobutrol.
METHODS: Rats bearing late-stage gliomas received 2.5 mmol/kg (392.5 mg Gd/kg) of gadopentetate dimeglumine (n = 5) and gadobutrol (n = 6) intravenously before the imaging session performed at the European Synchrotron Radiation Facility.
RESULTS: Monochromatic quantitative computed tomography enabled in vivo follow-up of Gd concentration as a function of time in specified regions of interest. Surprisingly, after gadobutrol injection, Gd concentrations in the center and periphery of the tumor were higher than those after gadopentetate injection, although identical in normal and contralateral area of the brain.
CONCLUSION: The in vivo assessment of absolute Gd concentrations revealed differences in gadobutrol and gadopentetate dimeglumine behaviors in tumoral tissues despite injections in the same conditions. These differences might be attributed to different characteristics of the contrast agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194909     DOI: 10.1097/01.rli.0000124250.61768.c0

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

1.  Comparative studies of different gadolinium agents in brain tumors: differences between gadolinium chelates and their possible influence on imaging features.

Authors:  N Anzalone
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 2.  MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.

Authors:  M Essig; N Anzalone; S E Combs; À Dörfler; S-K Lee; P Picozzi; A Rovira; M Weller; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-20       Impact factor: 3.825

3.  Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine.

Authors:  E S Kim; J H Chang; H S Choi; J Kim; S-K Lee
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-28       Impact factor: 3.825

4.  MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.

Authors:  Marc Saake; Soenke Langner; Carsten Schwenke; Marina Weibart; Olav Jansen; Norbert Hosten; Arnd Doerfler
Journal:  Eur Radiol       Date:  2015-06-30       Impact factor: 5.315

5.  Prolonged Blood-Brain Barrier Injury Occurs After Experimental Intracerebral Hemorrhage and Is Not Acutely Associated with Additional Bleeding.

Authors:  Colby A Nadeau; Kristen Dietrich; Cassandra M Wilkinson; Andrew M Crawford; Graham N George; Helen K Nichol; Frederick Colbourne
Journal:  Transl Stroke Res       Date:  2018-06-14       Impact factor: 6.829

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.